Back to today’s briefing

Story perspectives

FDA Approves Anzupgo: Breakthrough Cream for Hand Eczema

7/25/2025

23 2

Summary

Story summary

The FDA has granted approval for Leo Pharma's Anzupgo (delgocitinib) cream, marking a groundbreaking step as the first treatment for adults suffering from moderate to severe chronic hand eczema. This innovative topical pan-JAK inhibitor specifically targets inflammation, offering hope to those who have not found relief with corticosteroids. Following successful phase 3 trials, Anzupgo promises to enhance the quality of life for many.

1 of 1

Story summary

The FDA has granted approval for Leo Pharma's Anzupgo (delgocitinib) cream, marking a groundbreaking step as the first treatment for adults suffering from moderate to severe chronic hand eczema. This innovative topical pan-JAK inhibitor specifically targets inflammation, offering hope to those who have not found relief with corticosteroids. Following successful phase 3 trials, Anzupgo promises to enhance the quality of life for many.